Status:
COMPLETED
The Effects of Heated Tobacco Products Use on Lung Function and Volatile Organic Compounds in Exhaled Air
Lead Sponsor:
Karolinska Institutet
Collaborating Sponsors:
Swedish Heart Lung Foundation
Conditions:
Lung Inflammation
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
This is a human randomized controlled cross-over study where we investigate the effects of heated tobacco products (HTP) on lung function and on assessing volatile organic compounds in exhaled air.
Detailed Description
The World Health Organization estimates that smoking is one of the leading causes of premature death worldwide with an estimated 5-8 million lives lost annually due to tobacco usage. Heated tobacco p...
Eligibility Criteria
Inclusion
- • Healthy, free from medication
Exclusion
- Any form of cardiovascular disease
- Any form of pulmonary disease like asthma or COPD
- Any form of systemic or chronic disorder like rheumatologic or metabolic diseases. - Symptoms of infection or inflammation within 4 weeks of the study
- Pregnancy
Key Trial Info
Start Date :
October 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05260827
Start Date
October 1 2021
End Date
February 1 2023
Last Update
March 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institutionen för kliniska vetenskaper, Danderyds sjukhus
Danderyd, Stockholm County, Sweden, 18288